Back
Edgewise Therapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison
Buy
75
EWTX
Edgewise Therapeutics
Last Price:
36.38
Seasonality Move:
50.46%
Buy
68
VRTX
Vertex Pharmaceuticals
Last Price:
516.82
Seasonality Move:
6.39%
Buy
75
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $36.38. The Score for EWTX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $516.74. The Score for VRTX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $36.38
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $516.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.17 | Buy |
| Relative Strength Index (14 RSI): | 67.45 | Buy |
| Chaikin Money Flow: | 416594 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.85 - 35.87) | Buy |
| Bollinger Bands (100): | (16.58 - 29.92) | Buy |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.32 | Buy |
| Relative Strength Index (14 RSI): | 69.1 | Buy |
| Chaikin Money Flow: | 707634 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (463.95 - 492.55) | Buy |
| Bollinger Bands (100): | (466.25 - 490.85) | Buy |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.96 | Buy |
| 20-day SMA: | 34.46 | Buy |
| 50-day SMA: | 27.6 | Buy |
| 200-day SMA: | 20.37 | Buy |
| 8-day EMA: | 35.34 | Buy |
| 20-day EMA: | 33.68 | Buy |
| 50-day EMA: | 29.29 | Buy |
| 200-day EMA: | 20.9 | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 488.53 | Buy |
| 20-day SMA: | 482.44 | Buy |
| 50-day SMA: | 475.32 | Buy |
| 200-day SMA: | 451.94 | Buy |
| 8-day EMA: | 493.73 | Buy |
| 20-day EMA: | 483.69 | Buy |
| 50-day EMA: | 477.92 | Buy |
| 200-day EMA: | 450.84 | Buy |
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.33 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.57 per share, and an increase next year of $18.26 per share.
Edgewise Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||